Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Veliko Tirnovo – page 2

78 clinical trials in Veliko Tirnovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Veliko Tirnovo at a glance
78
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

78 trials in Veliko Tirnovo

Open in trial search

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Amgen Inc.

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Neurocrine Biosciences Inc.

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Bayer AG

Schizophrenia

Recruiting

A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:GXV813
  • Sponsor:Novartis Pharma AG

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Shionogi B.V.

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Veliko Tirnovo

What the registry says about research in the country

01 Cardiovascular Research

Extensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Research includes evaluation of new medications for reducing cardiovascular events and managing blood lipid levels.

  • Deep Vein Thrombosis Treatment
  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management

Trials are investigating novel approaches to cholesterol management and prevention of major adverse cardiovascular events.

02 Respiratory Medicine

Advanced research into chronic obstructive pulmonary disease (COPD) treatments and respiratory infections. Studies evaluate new therapeutic combinations and treatment efficacy.

  • COPD Treatment Optimization
  • Respiratory Syncytial Virus Therapy
  • Lung Function Improvement

Focus on developing improved inhalation therapies and testing new drug formulations for respiratory conditions.

03 Gastroenterology Studies

Innovative research in treating ulcerative colitis and inflammatory bowel conditions. Multiple trials exploring combination therapies and long-term treatment options.

  • Moderate to Severe Ulcerative Colitis
  • Novel Treatment Combinations
  • Long-term Disease Management

Emphasis on developing sustainable treatment approaches for chronic gastrointestinal conditions.

04 Mental Health Research

Comprehensive studies on major depressive disorder and other psychiatric conditions. Investigation of new therapeutic approaches for mental health management.

  • Schizophrenia Treatment
  • Bipolar Disorder Management
  • Depression Therapy

Focus on long-term safety and efficacy of new psychiatric medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.